CTT Pharmaceutical Holdings, Inc. filed a current report on October 30, 2026, disclosing that on October 27, 2026, the company signed an engagement letter with Zhanna Kelley, CPA as its new PCAOB auditor, following the prior resignation of Holt & Patterson.

Key Highlights

  • New auditor engaged: CTT Pharmaceutical Holdings signed an engagement letter with Zhanna Kelley, CPA on October 27, 2026, to serve as the company's PCAOB auditor going forward.
  • Prior auditor resigned: Holt & Patterson, the company's prior certifying public accountant, previously resigned, as reported in the company's filing dated October 7, 2026.
  • No disagreement cited: According to the filing, Holt & Patterson confirmed their resignation "was not due to any disagreement on any matter related to our accounting practices or anything contained in a report issued by us."
  • Registrant details: CTT Pharmaceutical Holdings, Inc. is a Florida-incorporated company headquartered at 1646 W Snow Ave, Suite 138, Tampa, FL 33606, trading on the OTCQB:CTTH.
  • Signed by CEO: The report was signed by Ryan Khouri, who serves as Chief Executive Officer and also as Principal Executive, Financial and Accounting Officer.

CTT Pharmaceutical Replaces Certifying Accountant After October Resignation

According to the filing, CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH), a Florida-incorporated pharmaceutical holding company based in Tampa, disclosed an auditor transition under Item 8.01 (Other Events). The company reported that its prior certifying public accountant, Holt & Patterson, had resigned, a development first disclosed in a current report filed on October 7, 2026. The filing states that Holt & Patterson confirmed their departure was not related to any disagreement over accounting practices or any previously issued reports.

On October 27, 2026, the company disclosed it signed an engagement letter with Zhanna Kelley, CPA, designating her as the company's PCAOB auditor on a going-forward basis. The filing does not provide additional details regarding the scope or terms of the engagement. Ryan Khouri, who holds the combined roles of Chief Executive Officer and Principal Executive, Financial and Accounting Officer, signed the report on behalf of the registrant on the same date.

The filing was submitted under Item 8.01 and includes only a Cover Page Interactive Data File (Exhibit 104) as an exhibit. No financial statements were attached. CTT Pharmaceutical Holdings maintains its principal offices at 1646 W Snow Ave, Suite 138, Tampa, FL 33606, and carries Commission File Number 333-292497.

What Was Disclosed

CTT Pharmaceutical Holdings disclosed the signing of an engagement letter with Zhanna Kelley, CPA as its new PCAOB auditor on October 27, 2026, following the resignation of prior accountant Holt & Patterson, which the company stated involved no disagreement over accounting matters.